A patient is beginning to take a combination estrogen-progestin ...

[scienceeasy]

A patient is beginning to take a combination estrogen-progestin product as an oral contraceptive (OC). Which symptom(s), if verbalized, demonstrates that the patient has knowledge of the ad-verse effects associated with this drug?
 
  a. Total loss of menses
  b. Reduced breast size
  c. Hypotension
  d. Hypertension

Question 2

A patient who is receiving anticoagulant therapy is also being started on estrogen therapy. Which action may the health care provider need to take because of the interaction of these drugs?
 
  a. Increase the dose of the anticoagulant.
  b. Decrease the dose of the anticoagulant.
  c. Increase the dose of estrogen.
  d. Add ascorbic acid to the therapy.

[leahm14]

Answer to Question 1

ANS: D
The estrogenic adverse effects from OCs include nausea, vomiting, breast tenderness and en-largement, hypertension and migraine headaches. Progestins can cause appetite increase, weight gain, fatigue, depression, and decreased libido.

Answer to Question 2

ANS: A
The action of clotting factors is increased by estrogen, thus diminishing the effects of oral anti-coagulants. Thus the anticoagulant dose may have to be increased.

[scienceeasy]

TY

[leahm14]

You're welcome